Active, Not Recruiting
Atezolizumab, Cobimetinib, and Eribulin in Treating Patients With Chemotherapy Resistant Metastatic Inflammatory Breast Cancer
NCT03202316
- Conditions
- Breast Diseases, Breast Neoplasms, Inflammatory Breast Neoplasms, +6 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States